FTIR spectral signature of the effect of cardiotonic steroids with antitumoral properties on a prostate cancer cell line

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1802, Issue 11, 2010, Pages 1087-1094

  Gasper, Régis ^a   Mijatovic, Tatjana ^a   Bénard, Audrey ^a   Derenne, Allison ^a   Kiss, Robert ^a   Goormaghtigh, Erik ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Cancer; Cardiotonic steroid; Drug; FTIR; IR spectroscopy; PC 3

Indexed keywords

19 HYDROXY 2'' OXOVORUSCHARIN; 19 HYDROXYHELLEBRIN; CARDIOTONIC AGENT; DOXORUBICIN; HELLEBRIN; OUABAIN; STEROID; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG STRUCTURE; HUMAN; HUMAN TISSUE; INFRARED SPECTROSCOPY; PRIORITY JOURNAL; PROSTATE CANCER;

ANTINEOPLASTIC AGENTS; BUFANOLIDES; CARDENOLIDES; CARDIAC GLYCOSIDES; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DOXORUBICIN; HUMANS; INHIBITORY CONCENTRATION 50; MALE; MOLECULAR STRUCTURE; OUABAIN; PRINCIPAL COMPONENT ANALYSIS; PROSTATIC NEOPLASMS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; THIAZOLES; TIME FACTORS;

STROPHANTHUS GRATUS;

EID: 77956652394     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2010.07.012     Document Type: Article

References (48)

1. Suggitt M., Bibby M.C. 50years of preclinical anticancer drug screening: empirical to target-driven approaches. Clin Cancer Res. 2005, 11:971-981.
2. Houck K.A., Kavlock R.J. Understanding mechanisms of toxicity: insights from drug discovery research. Toxicol. Appl. Pharmacol. 2008, 227:163-178.
3. Mijatovic T., Van Quaquebeke E., Delest B., Debeir O., Darro F., Kiss R. Cardiotonic steroids on the road to anti-cancer therapy. Biochim. Biophys. Acta 2007, 1776:32-57.
4. +-ATPase alpha subunits as new targets in anticancer therapy. Expert Opin. Ther. Targets 2008, 12:1403-1417.
5. Lefranc F., Kiss R. The sodium pump alpha1 subunit as a potential target to combat apoptosis-resistant glioblastomas. Neoplasia 2008, 10:198-206.
6. Prassas I., Diamandis E.P. Novel therapeutic applications of cardiac glycosides. Nat Rev Drug Discov. 2008, 7:926-935.
7. +-ATPase. J. Biol. Chem. 1994, 269:19659-19662.
8. Liang M., Tian J., Liu L.J., Pierre S., Liu J., Shapiro J., Xie Z.J. Identification of a pool of non-pumping Na/K-ATPase. J. Biol. Chem. 2007, 282:10585-10593.
9. Anderson R.G.W., Jacobson K. Cell biology - a role for lipid shells in targeting proteins to caveolae, rafts, and other lipid domains. Science 2002, 296:1821-1825.
10. Wang H.J., Haas M., Liang M., Cai T., Tian J., Li S.W., Xie Z.J. Ouabain assembles signaling cascades through the caveolar Na±/K±-ATPase. J. Biol. Chem. 2004, 279:17250-17259.
11. Xie Z., Cai T. Na±-K±-ATPase-mediated signal transduction: from protein interaction to cellular function. Mol. Interv. 2003, 3:157-168.
12. +-ATPase. Am. J. Physiol. Cell. Physiol. 2003, 284:C1550-C1560.
13. Dvela M., Rosen H., Feldmann T., Nesher M., Lichtstein D. Diverse biological responses to different cardiotonic steroids. Pathophysiology. 2007, 14:159-166.
14. Newman R.A., Yang P., Pawlus A.D., Block K.I. Cardiac glycosides as novel cancer therapeutic agents. Mol. Interv. 2008, 8:36-49.
15. +-ATPase is the Achilles Heel of multi-drug-resistant cancer cells. Cancer Lett. 2009, 282:30-34.
16. Lefranc F., Mijatovic T., Kondo Y., Sauvage S., Roland I., Debeir O., Krstic D., Vasic V., Gailly P., Kondo S., Blanco G., Kiss R. Targeting the alpha 1 subunit of the sodium pump to combat glioblastoma cells. Neurosurgery 2008, 62:211-221.
17. Mijatovic T., Mathieu V., Gaussin J.F., De Neve N., Ribaucour F., Van Quaquebeke E., Dumont P., Darro F., Kiss R. Cardenolide-induced lysosomal membrane permeabilization demonstrates therapeutic benefits in experimental human non-small cell lung cancers. Neoplasia 2006, 8:402-412.
18. Mijatovic T., Roland I., Van Quaquebeke E., Nilsson B., Mathieu A., Van Vynckt F., Darro F., Blanco G., Facchini V., Kiss R. The alpha1 subunit of the sodium pump could represent a novel target to combat non-small cell lung cancers. J Pathol. 2007, 212:170-179.
19. Mathieu V., Pirker C., de Lassalle E.M., Vernier M., Mijatovic T., DeNeve N., Gaussin J.F., Dehoux M., Lefranc F., Berger W., Kiss R. The sodium pump alpha 1 sub-unit: a disease progression-related target for metastatic melanoma treatment. J. Cell. Mol. Med. 2009, 13:3960-3972.
20. Naumann D., Helm D., Labischinski H. Microbiological characterizations by FT-IR spectroscopy. Nature 1991, 351:81-82.
21. Gaigneaux A., Ruysschaert J.M., Goormaghtigh E. Infrared spectroscopy as a tool for discrimination between sensitive and multiresistant K562 cells. Eur. J. Biochem. 2002, 269:1968-1973.
22. Wong P.T.T., Wong R.K., Caputo T.A., Godwin T.A., Rigas B. Infrared-spectroscopy of exfoliated human cervical cells - evidence of extensive structural-changes during carcinogenesis. Proc. Natl. Acad. Sci. U. S. A 1991, 88:10988-10992.
23. Rigas B., Wong P.T.T. Human colon adenocarcinoma cell-lines display infrared spectroscopic features of malignant colon tissues. Cancer Res 1992, 52:84-88.
24. Lasch P., Haensch W., Naumann D., Diem M. Imaging of colorectal adenocarcinoma using FT-IR microspectroscopy and cluster analysis. Biochim. Biophys. Acta. 2004, 1688:176-186.
25. Harz M., Rosch P., Popp J. Vibrational spectroscopy - a powerful tool for the rapid identification of microbial cells at the single-cell level. Cytometry A 2009, 75:104-113.
26. Wenning M., Seiler H., Scherer S. Fourier-transform infrared microspectroscopy, a novel and rapid tool for identification of yeasts. Appl Environ Microbiol 2002, 68:4717-4721.
27. Diem M., Chiriboga L., Lasch P., Pacifico A. IR spectra and IR spectral maps of individual normal and cancerous cells. Biopolymers 2002, 67:349-353.
28. Diem M., Romeo M., Boydston-White S., Miljkovic M., Matthaus C. A decade of vibrational micro-spectroscopy of human cells and tissue (1994-2004). Analyst 2004, 129:880-885.
29. Rigas B., Morgello S., Goldman I.S., Wong P.T.T. Human colorectal cancers display abnormal Fourier-Transform infrared-spectra. Proc. Natl. Acad. Sci. U. S. A 1990, 87:8140-8144.
30. Gaigneaux A., Decaestecker C., Camby I., Mijatovic T., Kiss R., Ruysschaert J.M., Goormaghtigh E. The infrared spectrum of human glioma cells is related to their in vitro and in vivo behavior. Exp. Cell Res. 2004, 297:294-301.
31. Gasper R., Dewelle J., Kiss R., Mijatovic T., Goormaghtigh E. IR spectroscopy as a new tool for evidencing antitumor drug signatures. Biochim. Biophys. Acta 2009, 1788:1263-1270.
32. Langenhan J.M., Peters N.R., Guzei I.A., Hoffmann M., Thorson J.S. Enhancing the anticancer properties of cardiac glycosides by neoglycorandomization. Proc. Natl. Acad. Sci. U. S. A 2005, 102:12305-12310.
33. Paz M. Antitumour Antibiotics. Anticancer Therapeutics 2008, 111-131. John Wiley & Sons Ltd, Chichester, West Sussex. S. Missailidis (Ed.).
34. Van Quaquebeke E., Simon G., Andre A., Dewelle J., El Yazidi M., Bruyneel F., Tuti J., Nacoulma O., Guissou P., Decaestecker C., Braekman J.C., Kiss R., Darro F. Identification of a novel cardenolide (2"-oxovoruscharin) from Calotropis procera and the hemisynthesis of novel derivatives displaying potent in vitro antitumor activities and high in vivo tolerance: structure-activity relationship analyses. J Med. Chem. 2005, 48:849-856.
35. [35] Mijatovic, T., Ingrassia, L., Van Quaquebeke, E., Van Den Hove, L, Darro, F., and Kiss, R., (2009), WO/2009/033505, PCT/EP2007/059699.
36. Goormaghtigh E., Raussens V., Ruysschaert J.M. Attenuated total reflection infrared spectroscopy of proteins and lipids in biological membranes. Biochim Biophys Acta. 1999, 1422:105-185.
37. Mourant J.R., Yamada Y.R., Carpenter S., Dominique L.R., Freyer J.P. FTIR spectroscopy demonstrates biochemical differences in mammalian cell cultures at different growth stages. Biophys J. 2003, 85:1938-1947.
38. Johnson R.A., Wichern D.W. Principal Components, Applied Multivariate Statistical Analysis 1998, 458-513. Prentice Hall, Upper Saddle River.
39. Ward J.H. Hierarchical grouping to optimize an objective function. J. Am. Stat. Assoc. 1963, 58:236-244.
40. Johnson R.A., Wichern D.W. Clustering, methods and ordination. Applied Multivariate Statistical Analysis 1998, 726-799. Prentice Hall, Upper Saddle River. R.A. Johnson, D.W. Wichern (Eds.).
41. Mantsch H., Jackson M. Molecular spectroscopy in biodiagnostics (from Hippocrates to Herschel and beyond). J Mol Struct. 1995, 347:187-206.
42. Naumann D. Infrared spectroscopy in microbiology. Encyclopedia of Analytical Chemistry 2000, 102-131. John Wiley & Sons Ltd, Chichester, West Sussex. R.A. Meyers (Ed.).
43. Goormaghtigh E., Cabiaux V., Ruysschaert J.M. Determination of soluble and membrane protein structure by Fourier transform infrared spectroscopy. I. Assignments and model compounds. Subcell. Biochem. 1994, 23:329-362.
44. Diem M., Boydston-White S., Chiriboga L. Infrared spectroscopy of cells and tissues: shining light onto a novel subject. Appl. Spectrosc. 1999, 53:148A-161A.
45. Lasch P., Boese M., Pacifico A., Diem M. FT-IR spectroscopic investigations of single cells on the subcellular level. Vib. Spectrosc. 2002, 28:147-157.
46. Mijatovic T., De N.N., Gailly P., Mathieu V., Haibe-Kains B., Bontempi G., Lapeira J., Decaestecker C., Facchini V., Kiss R. Nucleolus and c-Myc: potential targets of cardenolide-mediated antitumor activity. Mol. Cancer Ther. 2008, 7:1285-1296.
47. Draux F., Jeannesson P., Gobinet C., Sule-Suso J., Pijanka J., Sandt C., Dumas P., Manfait M., Sockalingum G.D. IR spectroscopy reveals effect of non-cytotoxic doses of anti-tumour drug on cancer cells. Anal. Bioanal. Chem. 2009, 395:2293-2301.
48. Eom Y.W., Kim M.A., Park S.S., Goo M.J., Kwon H.J., Sohn S., Kim W.H., Yoon G., Choi K.S. Two distinct modes of cell death induced by doxorubicin: apoptosis and cell death through mitotic catastrophe accompanied by senescence-like phenotype. Oncogene 2005, 24:4765-4777.